Position in VCEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,910,737
-$811,510 QoQ
Shares Held
59,395
-21.4% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. VCEL ranks #74 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in VCEL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,910,737 | 59,395 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,722,247 | 75,597 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,177,063 | 69,179 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,020,656 | 47,489 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,128,195 | 47,696 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,289,088 | 41,688 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,269,416 | 53,714 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,033,402 | 66,116 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,966,323 | 172,363 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,768,036 | 105,814 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,198,581 | 125,256 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,508,775 | 93,393 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,192,039 | 108,869 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,589,455 | 174,239 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,270,991 | 140,991 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,526,233 | 100,327 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,776,200 | 124,966 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,127,353 | 130,467 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,945,616 | 60,361 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,378,565 | 45,306 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,964,881 | 71,375 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $585,423 | 18,958 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $779,482 | 42,066 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $453,448 | 32,811 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||